Show simple item record

 
dc.contributorInstitut d'Assistència Sanitària
dc.contributor.authorMoreno Küstner, Berta
dc.contributor.authorFábrega-Ruz, Julia
dc.contributor.authorGONZALEZ-CABALLERO, JUAN-LUIS
dc.contributor.authorReyes-Martin, Sara
dc.contributor.authorOchoa, Susana
dc.contributor.authorROMERO LOPEZ-ALBERCA, CRISTINA
dc.contributor.authorVila-Badia, Regina
dc.contributor.authorFRIGOLA-CAPELL, EVA
dc.contributor.authorSalvador-Carulla, Luis
dc.contributor.authorCID COLOM, JORDI
dc.date.accessioned2024-07-12T08:06:00Z
dc.date.available2024-07-12T08:06:00Z
dc.date.issued2022-06
dc.identifier.citationMoreno‐Küstner B, Fábrega‐Ruz J, Gonzalez‐Caballero JL, Reyes‐Martin S, Ochoa S, Romero‐Lopez‐Alberca C, et al. Patient‐reported impact of symptoms in schizophrenia scale (PRISS): Development and validation. Acta psychiatrica Scandinavica 2022 Jun;145(6):640-655.
dc.identifier.issn1600-0447
dc.identifier.urihttps://hdl.handle.net/11351/11701
dc.descriptionPatient-reported outcome; Schizophrenia; Subjective experiences
dc.description.abstractBackground.We report the psychometric properties of the Patient-Reported Impact of Symptoms in Schizophrenia Scale (PRISS), which assesses the impact of subjective experiences or qualia in outpatients with this condition.Methods.A cross-sectional study was carried out in 162 patients diagnosed with schizophrenia in Spain. The PRISS measures the presence, frequency, concern and interference with daily life of self-reported experiences related to the main symptoms observed in these patients. The psychometric analysis included test-retest reliability, internal consistency and structural and convergent validity.Results.The 28-item PRISS showed good test-retest reliability as 64.3% of the intraclass correlation coefficient values were between 0.40 and 0.79, which were statistically significant (p < 0.01). Analysis of the structural validity revealed a three-factor structure, (1) productive subjective experiences, (2) affective-negative subjective experiences and (3) excitation, which accounted for 56.11% of the variance. Of the Pearson's correlation coefficients analysed between the PRISS and the Positive and Negative Syndrome Scale (PANSS), Scale for Assessment of Negative Symptoms (SANS) and World Health Organization Disability Assessment Schedule (WHO-DAS), 72.2% were statistically significant (p < 0.05) and ranged from 0.38–0.42, 0.32–0.42 and 0.40–0.42, respectively.Conclusion.Our results indicate that the PRISS appears to be a brief, reliable and valid scale to measure subjective experiences in schizophrenia and provides valuable information complementary to clinical evaluation.
dc.language.isoeng
dc.publisherJohn Wiley & Sons
dc.relation.ispartofseriesActa Psychiatrica Scandinavica;145(6)
dc.rightsAttribution-NonCommercial 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/
dc.sourceScientia
dc.subjectEsquizofrènia-Pacients
dc.subjectPsicometria
dc.subject.meshSchizophrenia
dc.subject.meshPsychometrics
dc.titlePatient-reported impact of symptoms in schizophreniascale (PRISS): Development and validation
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1111/acps.13417
dc.subject.decsesquizofrenia
dc.subject.decspsicometría
dc.relation.publishversionhttps://doi.org/10.1111/acps.13417
dc.audienceProfessionals
dc.event.productorBiblioteca
dc.contributor.authoraffiliation[Moreno-Küstner B] Department of Personality, Assessment and Psychological Treatment, University of Malaga, Malaga, Spain. Andalusian Group of Psychosocial Research (GAP), Andalucía, Spain. Biomedical Research Institute of Malaga (IBIMA), Málaga, Spain. Asociación Científica Psicost, Cádiz, Spain [Fábrega-Ruz J] Mental Health Department, Regional University Hospital of Malaga, University of Malaga, Málaga, Spain [Gonzalez- Caballero JL] Asociación Científica Psicost, Cádiz, Spain. Department of Statistics and Operational Research, Faculty of Medicine, University of Cadiz, Cádiz, Spain [Reyes- Martin S] Biomedical Research Institute of Malaga (IBIMA), Málaga, Spain [Ochoa S] Asociación Científica Psicost, Cádiz, Spain. Etiopathogenesis and treatment of severe mental disorders Group (MERITT), Institut de Recerca Sant Joan de Déu, Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain. Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain [Romero-Lopez-Alberca C] Asociación Científica Psicost, Cádiz, Spain. Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain. Department of Psychology, University of Cadiz, Cádiz, Spain. [Cid J] Asociación Científica Psicost, Cádiz, Spain. Institut d'Assistència Sanitària de Girona, Girona, Spain. Mental Health & Addiction Research Group, Institut d'Investigació Biomèdica de Girona (IDIBGI), Girona, Spain. [Vila-Badia R] Etiopathogenesis and treatment of severe mental disorders Group (MERITT), Institut de Recerca Sant Joan de Déu, Parc Sanitari Sant Joan de Déu, Sant Boi de Llobregat, Barcelona, Spain. Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain. [Frigola-Capell E] Institut d'Assistència Sanitària de Girona, Girona, Spain. Mental Health & Addiction Research Group, Institut d'Investigació Biomèdica de Girona (IDIBGI), Girona, Spain [Salvador- Carulla L] Asociación Científica Psicost, Cádiz, Spain. Health Research Institute, Faculty of Health, University of Canberra, Canberra, Australia. Menzies Centre for Mental Health Policy, Sydney School of Public Health, University of Sydney, Sydney, Australia
dc.identifier.pmid35188673
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record